- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03925948
Health Literacy Intervention for African Americans With Diabetes
April 22, 2019 updated by: Johns Hopkins University
Health Literacy Enhanced Intervention for Inner-city African Americans With Uncontrolled Diabetes: A Pilot Study
Disparities in diagnosis and control of type 2 diabetes mellitus are most evident in African Americans (AAs) with lower socioeconomic status.
Health literacy is an important predictor of adequate self-management and control of diabetes.
The purpose of this pilot study was to test the feasibility and preliminary efficacy of a health literacy-enhanced diabetes intervention -Prevention through Lifestyle intervention And Numeracy (PLAN) 4 Success-Diabetes, in inner-city, low-income AAs with uncontrolled diabetes.
To evaluate the feasibility, acceptability, and preliminary efficacy of the intervention, the investigators conducted a pilot study with 24-week follow-up.
The investigators that participation in the PLAN 4 Success-diabetes intervention would be associated with a reduction in glucose outcomes and improvements in psychosocial variables.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
19
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21205
- Wald Community Nursing Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- African Americans residing in Baltimore, Maryland
- had uncontrolled diabetes (defined as HbA1C>7%)
Exclusion Criteria:
- Unable to give informed consent
- Physical or mental health conditions that could limit active participation in the study (e.g., blindness in both eyes, severe immobility, psychiatric diseases)
- Hematological condition that would affect HbA1C assay, e.g., hemolytic anemia, sickle cell anemia
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Intervention
This is a one arm study with all participants enrolled into this arm.
|
The study intervention-PLAN 4 Success-Diabetes-consisted of four 1 to 1 ½-hour weekly health literacy training and disease knowledge education sessions for four weeks (4 in-person sessions), followed by two home visits and monthly phone counseling for over 6 months (5 phone sessions).
The intervention is theory-driven and builds on von Wagner's model to incorporate key elements such as health literacy, disease knowledge, and self-efficacy for better glucose outcomes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Health literacy as assessed by Literacy Assessment in Diabetes (LAD).
Time Frame: baseline; 12 and 24 weeks
|
The Literacy Assessment in Diabetes (LAD) has high reliability and validity indices.
The items on the LAD are scored as correct/incorrect, with total possible scores ranging from 0 to 60. Higher scores indicated higher health literacy levels.
|
baseline; 12 and 24 weeks
|
Change in Health literacy as assessed by the Newest Vital Sign
Time Frame: baseline; 12 and 24 weeks
|
The Newest Vital Sign consists of four items and measures numeracy.
After reviewing a nutrition label, participants are asked to answer questions based on some calculation of the nutritional information (e.g., fat, sodium) presented on the label.
Total possible scores range from 0 to 4, with one point assigned for each correct response.
|
baseline; 12 and 24 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Diabetes knowledge measured with the validated Diabetes Knowledge Test
Time Frame: baseline; 12 and 24 weeks
|
The Diabetes Knowledge Test assesses diabetes knowledge, medications, diet, and management with questions such as "What effect will an infection most likely have on blood glucose."
Correct responses are given a score of one.
|
baseline; 12 and 24 weeks
|
Change in Diabetes self-efficacy measured with Stanford Diabetes Self-Efficacy scale
Time Frame: baseline; 12 and 24 weeks
|
The Stanford Diabetes Self-Efficacy scale assesses participant's efficacy in managing diabetes and maintaining healthy lifestyles.
The scale asks how confident participants are in managing different tasks such as eating meals every 4 to 5 hours every day or breakfast every day measured on a Likert scale of 0 "not at all confident" to 10 "totally confident."
Participant scores are the means across all items in the instrument.
|
baseline; 12 and 24 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Diabetes self-care index
Time Frame: baseline; 12 and 24 weeks
|
This index included seven questions on smoking, alcohol consumption, meal planning, consumption of high fat foods, consumption of high sugar foods, consumption of sodium, and medium or high intensity exercise.
These questions were coded into dichotomous responses with participation in healthy behaviors coded as "1" and active participation in negative health behaviors coded as "0".
A summary score for the index could range 0-7 and higher scores indicate better self-care.
|
baseline; 12 and 24 weeks
|
Change in Social support as assessed by modified Medical Outcomes Study-Social Support Survey (mMOS-SS)
Time Frame: baseline; 12 and 24 weeks
|
mMOS-SS is a shorter version (10 items) of the Medical Outcomes Study-Social Support Survey (MOS-SS) which includes 19 items.
The original version was used to measure social support in community dwelling chronically ill persons.
mMOS-SS covers emotional and instrumental domains of social support with strong evidence of reliability and validity.
Example items include: "How often is someone available to take you to the doctor if you need it" or "How often is someone available who understands your problems?"
Response options are from all of the time (5 point) to none of the time (1 point) with higher scores indicating higher levels of social support (total score range=10 to 50).
|
baseline; 12 and 24 weeks
|
Change in Depression status as assessed by the Patient Health Questionnaire (PHQ)-9
Time Frame: baseline; 12 and 24 weeks
|
The Patient Health Questionnaire (PHQ)-9 addresses the severity of depressive symptoms based on the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV).
The PHQ-9 has 9 items scored from 0 (not at all) to 3 (nearly every day) with total scores ranging from 0 to 27.
Individuals are asked whether any symptom(s) have been experienced over the past 2 weeks.
Evidence of reliability, validity, sensitivity, and specificity has been reported in community samples.
|
baseline; 12 and 24 weeks
|
Change in Quality of Life as assessed by the EuroQol Quality of Life scale
Time Frame: baseline; 12 and 24 weeks
|
It contains the EQ-5D-3L that provides a single index of health status.
The EQ-5D-3L assess five domains; mobility, self-care, usual activities, pain/discomfort and anxiety/depressions.
Responses show if participants do not have difficulty, have some problems or have severe difficulty within the domains.
Summary scores for the sample were created across each of the five items (range 0-2) with higher scores indicating better quality of life.
A component of this scale is the EuroQol visual analogue scale (EQ-VAS) which participants can use a number from 0-100 to identify participant's health state.
|
baseline; 12 and 24 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- von Wagner C, Steptoe A, Wolf MS, Wardle J. Health literacy and health actions: a review and a framework from health psychology. Health Educ Behav. 2009 Oct;36(5):860-77. doi: 10.1177/1090198108322819. Epub 2008 Aug 26.
- Han HR, Nkimbeng M, Ajomagberin O, Grunstra K, Sharps P, Renda S, Maruthur N. Health literacy enhanced intervention for inner-city African Americans with uncontrolled diabetes: a pilot study. Pilot Feasibility Stud. 2019 Aug 8;5:99. doi: 10.1186/s40814-019-0484-8. eCollection 2019.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
May 6, 2015
Primary Completion (ACTUAL)
February 1, 2019
Study Completion (ACTUAL)
February 1, 2019
Study Registration Dates
First Submitted
April 22, 2019
First Submitted That Met QC Criteria
April 22, 2019
First Posted (ACTUAL)
April 24, 2019
Study Record Updates
Last Update Posted (ACTUAL)
April 24, 2019
Last Update Submitted That Met QC Criteria
April 22, 2019
Last Verified
April 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00061339
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Uncontrolled Diabetes
-
Mansoura UniversityNot yet recruitingDiabetes | Uncontrolled DiabtetesEgypt
-
Tehran University of Medical SciencesCompletedUncontrolled Type 2 Diabetes MellitusIran, Islamic Republic of
-
Cadila PharnmaceuticalsNew Millennium Indian Technology Leadership Initiative (NMITLI) program of...CompletedUncontrolled Type 2 Diabetes MellitusIndia
-
Universiti Sains MalaysiaClinical Research Centre, Malaysia; Malaysia Palm Oil BoardTerminatedUncontrolled Insulin-treated Type 2 Diabetes MellitusMalaysia
-
University of PretoriaNestlè Nutrition Institute Africa; South African Sugar AssociationCompletedDiabetes Mellitus, Type II [Non-insulin Dependent Type] [NIDDM Type] UncontrolledSouth Africa
-
Hadassah Medical OrganizationUnknownUncontrolled Type 1 Diabetic Patients
-
Alcon ResearchCompletedUncontrolled Intraocular PressureIndia
-
AstraZenecaNot yet recruiting
-
CVRx, Inc.Suspended
-
Verve Medical, IncClinical Accelerator (CRO); Israeli-Georgian Medical Research Clinic Helsicore and other collaboratorsActive, not recruitingHypertension | Uncontrolled HypertensionGeorgia
Clinical Trials on PLAN 4 Success-Diabetes
-
Centre Hospitalier Universitaire de NīmesTerminatedUrinary Incontinence, StressFrance
-
University of Wisconsin, MadisonPenn State UniversityCompletedPovertyUnited States
-
Medifast, Inc.Completed
-
Helse Nord-Trøndelag HFNorwegian University of Science and TechnologyCompletedHypoglycemia | Obesity, MorbidNorway
-
University of Wisconsin, MadisonPenn State UniversityCompletedObesity | Poverty
-
The Royal Wolverhampton Hospitals NHS TrustCompletedDiabetes | Care DeliveryUnited Kingdom
-
University of AlbertaCompletedType 2 Diabetes
-
Mondelēz International, Inc.KGK Science Inc.Completed
-
Abbott NutritionCompletedDiabetes Mellitus, Type 2United States
-
Children's National Research InstituteAmerican Diabetes AssociationActive, not recruitingType 1 Diabetes MellitusUnited States